{"text_format":"3","workbook":"xls","n_sheets":1,"sheets":["additionalfile3"],"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"additionalfile3","index":0,"n_rows":34,"n_cols":4,"rows_kept":34,"flags":["formulas_cached_only"]}
["Additional file 3: up-regulated pathways in VIR group versus BDLs from GSEA"]
["Immunology"]
["Gene set name","Gene set size","NOM p-val","FDR"]
["KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION",48,{"v":0,"d":"0.00"},{"v":0.0144338505,"d":"0.014"}]
["KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION",88,{"v":0.001908397,"d":"0.00"},{"v":0.01639986,"d":"0.016"}]
["KEGG_LYSOSOME",119,{"v":0,"d":"0.00"},{"v":0.022524381,"d":"0.023"}]
["KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS",92,{"v":0.0019230769,"d":"0.00"},{"v":0.029464886,"d":"0.029"}]
["KEGG_CHEMOKINE_SIGNALING_PATHWAY",185,{"v":0,"d":"0.00"},{"v":0.03766758,"d":"0.038"}]
["KEGG_COMPLEMENT_AND_COAGULATION_CASCADES",68,{"v":0.007920792,"d":"0.01"},{"v":0.038142856,"d":"0.038"}]
["KEGG_HEMATOPOIETIC_CELL_LINEAGE",87,{"v":0,"d":"0.00"},{"v":0.016930686,"d":"0.017"}]
["KEGG_NEUROTROPHIN_SIGNALING_PATHWAY",125,{"v":0,"d":"0.00"},{"v":0.025132986,"d":"0.025"}]
["KEGG_ADHERENS_JUNCTION",73,{"v":0,"d":"0.00"},{"v":0.016453916,"d":"0.016"}]
["KEGG_CELL_ADHESION_MOLECULES_CAMS",134,{"v":0,"d":"0.00"},{"v":0.017676227,"d":"0.018"}]
["Disease"]
["Gene set name","Gene set size","NOM p-val","FDR"]
["KEGG_LEISHMANIA_INFECTION",68,{"v":0,"d":"0.00"},{"v":0.004894146,"d":"0.005"}]
["KEGG_VIRAL_MYOCARDITIS",71,{"v":0,"d":"0.00"},{"v":0.008228525,"d":"0.008"}]
["KEGG_GRAFT_VERSUS_HOST_DISEASE",41,{"v":0,"d":"0.00"},{"v":0.013086152,"d":"0.013"}]
["KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS",129,{"v":0,"d":"0.00"},{"v":0.011630196,"d":"0.012"}]
["KEGG_ALLOGRAFT_REJECTION",38,{"v":0,"d":"0.00"},{"v":0.009516038,"d":"0.010"}]
["KEGG_ASTHMA",30,{"v":0.003960396,"d":"0.00"},{"v":0.012446737,"d":"0.012"}]
["KEGG_AUTOIMMUNE_THYROID_DISEASE",53,{"v":0.0018761726,"d":"0.00"},{"v":0.012473192,"d":"0.012"}]
["KEGG_TYPE_I_DIABETES_MELLITUS",44,{"v":0,"d":"0.00"},{"v":0.015073498,"d":"0.015"}]
["KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION",53,{"v":0.005882353,"d":"0.01"},{"v":0.034597613,"d":"0.035"}]
["KEGG_PRIMARY_IMMUNODEFICIENCY",35,{"v":0.012121212,"d":"0.01"},{"v":0.047450572,"d":"0.047"}]
["Metabolism"]
["Gene set name","Gene set size","NOM p-val","FDR"]
["KEGG_GLYCOLYSIS_GLUCONEOGENESIS",62,{"v":0.0021008404,"d":"0.00"},{"v":0.01379128,"d":"0.014"}]
["KEGG_OTHER_GLYCAN_DEGRADATION",15,{"v":0.002008032,"d":"0.00"},{"v":0.018115513,"d":"0.018"}]
["KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM",34,{"v":0.008230452,"d":"0.01"},{"v":0.030905092,"d":"0.031"}]
["KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS",25,{"v":0.015533981,"d":"0.02"},{"v":0.040463038,"d":"0.040"}]
["KEGG_CITRATE_CYCLE_TCA_CYCLE",32,{"v":0.01750547,"d":"0.02"},{"v":0.04404734,"d":"0.044"}]
["KEGG_PENTOSE_PHOSPHATE_PATHWAY",26,{"v":0.021912351,"d":"0.02"},{"v":0.048103936,"d":"0.048"}]
["Gene set size: number of genes in a particular gene set; NOM p-val: nominal p value; FDR: false discovery rate"]